$COST

Jim Cramer: 'Costco's in a funk' but still a good name in a bad neighborhood

Costco reported June sales rose 10.6% year over year to $29.4B, slightly below expectations, with U.S. comps excluding gasoline up 7.6% versus 8.7% in May. Shares fell over 4%. Analysts cited “fine” results but below lofty expectations; valuation is about 41x forward earnings. Costco membership growth also slowed, and it will release July sales Aug. 5.

Original reporting
Published Jul 9, 2026, 6:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 9, 2026, 6:43 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Jim Cramer: 'Costco's in a funk' but still a good name in a bad neighborhood — source image
Decision brief

The 30-second read

$COSTBearishMed
01

Why it matters

Fresh monthly sales and comp deceleration, plus a premium valuation discussion, increases sensitivity to any further slowing ahead of the next sales release and earnings.

02

Market read

Traders get a concrete monthly datapoint (sales, comps, traffic, ticket, e-commerce) and an immediate market reaction, informing positioning into upcoming sales and earnings dates.

03

What to watch

Membership growth is only quarterly and renewal rate held steady at 89.7%, so investors may be over-weighting monthly comps versus longer-term member economics.

Relevance 7/10Novelty 6/10Timing: after-hours/Thursday reaction to late-Wednesday June sales release; next catalyst is July sales on Aug. 5 and earnings on Sept. 24

Background

The piece frames Costco’s June monthly sales as a test of whether the company’s defensive profile can offset a weakening consumer backdrop.

Company-level read

Ticker impact

$COSTBearishMedium confidence
Context

Costco reported June sales up 10.6% YoY, with U.S. ex-gas comps slowing to 7.6% and shares falling more than 4% on Thursday.

Expected impact

Near-term downside bias as investors weigh slowing comps against Costco’s premium forward multiple.

Evidence & confidence

The article provides fresh monthly sales/comps data and notes the immediate stock reaction, plus commentary that elevated valuation leaves less room for disappointment.

Market effects

Signals that even defensive big-box retailers are seeing consumer pressure, consistent with broader retail ETF underperformance and survey weakness.

No explicit regional breakdown beyond U.S. comparables; read-across is primarily domestic consumer demand.

Limited global detail, but the mention of worldwide traffic and digital growth suggests resilience pockets even as comps slow.

Counterpoint

The slowdown is modest and Costco still shows positive traffic, ancillary strength (gas/pharmacy), and accelerating e-commerce, which can cushion earnings despite softer comps.

Key entities

  • Costco Wholesale

    Reported June sales growth of 10.6% YoY and slowed U.S. ex-gas comps to 7.6%, with shares down more than 4% Thursday.

  • Mizuho

    Cited expectations for U.S. ex-gas comps of 8% to 9% and characterized the report as fine but not as strong as it could be.

  • Wells Fargo

    Said results fell short of lofty expectations without changing Costco’s competitive position.

  • KeyBanc Capital Markets

    Surveyed consumers and found spending intentions and financial confidence weakened from March to June.

Related articles

$PGMed

Drugmakers, retailers must face ’maximum strength’ claim in decongestant false ad litigation in US

Nasdaq sees best day in over a month as Microsoft breathes life back into AI trade By Jonathan Stempel NEW YORK, July 30 (Reuters) - A federal appeals court on Thursday revived portions of nationwide litigation in which consumers accused drugmakers such as Procter & Gamble and retailers such as CVS of selling billions of dollars of over-the-counter decongestants that didn’t work. The litigation comprised about 100 lawsuits filed after a U.S.

$CRCLMed

Here Are Monday’s Best Wall Street Analyst Research Calls: Atmos Energy, Best Buy, Biogen, Capital One, Costco, Disney, Papa John’s International, Shopify, and More

The article lists Monday analyst calls and market moves. It highlights SK hynix’s Nasdaq debut, up about 12.8% to $168.01 after raising nearly $26.5B. It cites upgrades including BIIB to Buy at $235, COF to Buy at $229, and SHOP to Buy at $160, plus downgrades like BBY to Hold. Circle (CRCL) rose ~15% on OCC approval.

$COSTMed

Slowing Costco Sales Growth Unnerves Investors

Costco shares fell 4.1% on Thursday after a June sales update showed slower growth. Net sales rose 10.6% in June, the slowest since February, versus 14% in May. The stock closed at $912.97, down from a $1,094.32 May 19 high. D.A. Davidson reiterated a $1,000 price target.